Skip to main content
. 2016 Nov 21;6:37417. doi: 10.1038/srep37417

Figure 1. Pterostilbene inhibits cell proliferation in DLBCL cell lines.

Figure 1

(A) Six DLBCL cell lines were treated with pterostilbene at various concentrations (12.5–100 μM) in serum-containing medium for 48 h, then cell viability was monitored by CCK-8 assay. (B) SUDHL-4, (C) DB and (D) NU-DUL-1 cells were treated with pterostilbene at various concentrations (12.5–100 μM) and time points (24, 48 and 72 h), then cell viability was monitored by CCK-8 assay. The results of the untreated group were taken as 0%.